Science ❯Biotechnology ❯Vaccine Development

Infectious Diseases

Mpox Avian Flu Vaccine

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

The biotech company faces declining demand for its COVID-19 vaccine, a $238M manufacturing charge, and reduced 2025 revenue forecasts.

Moderna's mRNA Vaccine Shows Superior Mpox Protection in Animal Studies